Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Recent patent covers antiinflammatory agents from Ajinomoto

Feb. 22, 2001

FDA advisory committee recommends changes in Vioxx and Celebrex labeling

Feb. 22, 2001

Merck reports compounds with the ability to inhibit cytokine production or activity

Feb. 21, 2001

AtheroGenics moves second product into clinical development

Feb. 21, 2001

Review of Aslera NDA rescheduled for April

Feb. 21, 2001

Sankyo presents new cytokine production inhibitors in recent patent

Feb. 20, 2001

Cytokine inhibitors in the Merck pipeline

Feb. 19, 2001

Toleragen candidate for APS reduces disease-causing antibodies, corrects clotting defect in animals

Feb. 16, 2001

Preparation, activity and use of specific IkappaB kinase inhibitors claimed by Aventis

Feb. 15, 2001

Beneficial effects of long-term glucosamine sulfate on osteoarthritis progression

Feb. 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...